drugset / Trial / NCT01580254

Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma

NCT01580254

Phase 4 Unknown 120 enrolled University of Catanzaro
RandomizedParallel-groupDouble-blindTreatment

Summary

This study examines efficacy and tolerability of 3 different Latanoprost 0.005% eyedrops preparations, commercially available in Italy, in subjects affected by primary open angle glaucoma.

Timeline

Start
2011-06
Primary completion
2012-06
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Topical

Indications